Feasibility biomechanical study of injectable Biphasic Calcium Phosphate bone cement augmentation of the proximal femoral nail antirotation (PFNA) for the treatment of two intertrochanteric fractures using cadaveric femur
- 13 June 2024
- journal article
- research article
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 10 (4) , 045043
Abstract
This study evaluated the feasibility of the femoral bone after fixation using biphasic calcium phosphate cement-augmentation of the proximal femoral nail antirotation (PFNA) compared with PFNA without cement. This study presented to compare the stiffness, fatigue testing, and compressive strength between stable (AO31-A2.1) and unstable (AO31-A3.3) intertrochanteric fractures treated by cement augmented PFNA of the cadaveric femoral. Biphasic calcium phosphate cement was injected to align and compatible with PFNA and the reconstructive procedure was monitored the cement placement using x-ray imaging during operation. The testing demonstrated that the cement could be injected through a small needle (13 G, 16 cm length, 1.8 mm inner diameter) within a suitable operating time. The feasibility study of the biomechanical testing was divided into three tests: stiffness test, fatigue cyclic load, and compression test. The results showed that the cement-augmented specimens exhibited higher stiffness than the control specimens without cement. The cement-augmented specimens also showed lower strain energy during the fatigue test, resulting in higher compressive strength (4730.7 N) compared to the control specimens (3857.4 N). There is a correlation between BMD and fracture load and the increase in compression load of the cement-augmented femoral compared to the controls as well as an increase in strain energy of fatigue cyclic testing was found. Biphasic calcium phosphate cement-augmented of the PFNA biomechanically enhanced the cut-out resistance in intertrochanteric fracture. This procedure is especially efficient for unstable intertrochanteric fracture suggesting the potential benefits of using biphasic calcium phosphate cement in medical applications.Keywords
Funding Information
- National Research Council of Thailand
- Suranaree University of Technology
- Thailand Science Research and Innovation
- National Science, Research and Innovation Fund (NSRF; project code 90464)
This publication has 19 references indexed in Scilit:
- Cement augmentation of the Proximal Femur Nail Antirotation (PFNA) is associated with enhanced weight-bearing in older adultsInjury, 2021
- Risk factors for mechanical failure of intertrochanteric fractures after fixation with proximal femoral nail antirotation (PFNA II): a study in a Southeast Asian populationArchives of orthopaedic and trauma surgery, 2020
- Comparative finite element analysis of three implants fixing stable and unstable subtrochanteric femoral fractures: Proximal Femoral Nail Antirotation (PFNA), Proximal Femoral Locking Plate (PFLP), and Reverse Less Invasive Stabilization System (LISS)Orthopaedics & Traumatology: Surgery & Research, 2020
- Cement augmentation of the Proximal Femoral Nail Antirotation (PFNA) – A multicentre randomized controlled trialInjury, 2018
- Bioceramics for Osteochondral Tissue Engineering and Regeneration2018
- Long-term results of the augmented PFNA: a prospective multicenter trialArchives of orthopaedic and trauma surgery, 2013
- Cement augmentation of the proximal femoral nail antirotation for the treatment of osteoporotic pertrochanteric fractures—A biomechanical cadaver studyInjury, 2013
- Biomechanical evaluation of bone-cement augmented Proximal Femoral Nail Antirotation blades in a polyurethane foam model with low densityClinical Biomechanics, 2012
- The comparison of two classifications for trochanteric femur fractures: The AO/ASIF classification and the Jensen classificationInjury, 2010
- Finite element simulation of cement‐bone interface micromechanics: A comparison to experimental resultsJournal of Orthopaedic Research, 2009